Startups
Manufacturer of oral drugs that specifically inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1).
Summary
43
Industry
Total funding Amount
$56M
Fundraising History
-
Mar 01 '21 Series B$41M
-
Nov 21 '17 Series A$16M
-
Jul 02 '14 Seed$2.7M
Investors
-
Hadean VenturesSeries B
-
BpifranceSeries A
-
Idinvest PartnersSeed
-
AGORANOVSeed